---
document_datetime: 2024-09-05 09:33:58
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/reagila-epar-all-authorised-presentations_en.pdf
document_name: reagila-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.731886
conversion_datetime: 2025-12-19 05:33:07.601224
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

EU/1/17/1209/001

EU/1/17/1209/002

EU/1/17/1209/003

EU/1/17/1209/004

EU/1/17/1209/005

EU/1/17/1209/006

EU/1/17/1209/007

EU/1/17/1209/008

EU/1/17/1209/009

EU/1/17/1209/010

EU/1/17/1209/011

EU/1/17/1209/012

EU/1/17/1209/013

EU/1/17/1209/014

EU/1/17/1209/015

EU/1/17/1209/016

EU/1/17/1209/017

EU/1/17/1209/018

EU/1/17/1209/019

EU/1/17/1209/020

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

1.5 mg

1.5 mg

1.5 mg

1.5 mg

1.5 mg

1.5 mg

1.5 mg

1.5 mg

1.5 mg

1.5 mg

3 mg

3 mg

3 mg

3 mg

3 mg

3 mg

3 mg

3 mg

3 mg

3 mg

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

7 capsules

14 capsules

28 capsules

30 capsules

49 capsules

56 capsules

60 capsules

84 capsules

90 capsules

98 capsules

7 capsules

14 capsules

28 capsules

30 capsules

49 capsules

56 capsules

60 capsules

84 capsules

90 capsules

98 capsules

<div style=\"page-break-after: always\"></div>

## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

EU/1/17/1209/021

EU/1/17/1209/022

EU/1/17/1209/023

EU/1/17/1209/024

EU/1/17/1209/025

EU/1/17/1209/026

EU/1/17/1209/027

EU/1/17/1209/028

EU/1/17/1209/029

EU/1/17/1209/030

EU/1/17/1209/031

EU/1/17/1209/032

EU/1/17/1209/033

EU/1/17/1209/034

EU/1/17/1209/035

EU/1/17/1209/036

EU/1/17/1209/037

EU/1/17/1209/038

EU/1/17/1209/039

EU/1/17/1209/040

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

Reagila

4.5 mg

4.5 mg

4.5 mg

4.5 mg

4.5 mg

4.5 mg

4.5 mg

4.5 mg

6 mg

6 mg

6 mg

6 mg

6 mg

6 mg

6 mg

6 mg

1.5 mg

3 mg

4.5 mg

6 mg

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Capsule, hard

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

blister

(PVC/PE/PVDC/alu)

28 capsules

30 capsules

49 capsules

56 capsules

60 capsules

84 capsules

90 capsules

98 capsules

28 capsules

30 capsules

49 capsules

56 capsules

60 capsules

84 capsules

90 capsules

98 capsules

21 capsules

21 capsules

21 capsules

21 capsules

<div style=\"page-break-after: always\"></div>

## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/17/1209/041   | Reagila   | 4.5 mg   | Capsule, hard         | Oral use   | blister (PVC/PE/PVDC/alu)           | 7 capsules   |
|--------------------|-----------|----------|-----------------------|------------|-------------------------------------|--------------|
| EU/1/17/1209/042   | Reagila   | 6 mg     | Capsule, hard         | Oral use   | blister (PVC/PE/PVDC/alu)           | 7 capsules   |
| EU/1/17/1209/043   | Reagila   | 1.5 mg   | Orodispersible tablet | Oral use   | blister (PA/alu/PVC/paper/PE T/alu) | 28 tablets   |
| EU/1/17/1209/044   | Reagila   | 1.5 mg   | Orodispersible tablet | Oral use   | blister (PA/alu/PVC/paper/PE T/alu) | 30 tablets   |
| EU/1/17/1209/045   | Reagila   | 3 mg     | Orodispersible tablet | Oral use   | blister (PA/alu/PVC/paper/PE        | 28 tablets   |
| EU/1/17/1209/046   | Reagila   | 3 mg     | Orodispersible tablet | Oral use   | T/alu) blister (PA/alu/PVC/paper/PE | 30 tablets   |
| EU/1/17/1209/047   | Reagila   | 4.5 mg   | Orodispersible tablet | Oral use   | blister (PA/alu/PVC/paper/PE T/alu  | 28 tablets   |
| EU/1/17/1209/048   | Reagila   | 4.5 mg   | Orodispersible tablet | Oral use   | blister (PA/alu/PVC/paper/PE T/alu) | 30 tablets   |
| EU/1/17/1209/049   | Reagila   | 6 mg     | Orodispersible tablet | Oral use   | blister (PA/alu/PVC/paper/PE T/alu) | 28 tablets   |
| EU/1/17/1209/050   | Reagila   | 6 mg     | Orodispersible tablet | Oral use   | blister (PA/alu/PVC/paper/PE T/alu) | 30 tablets   |